Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BAVA | Copenhagen | DKK | Real-time | |
BAVAc | BATS Europe | DKK | Delayed | |
BVNRY | OTC Markets | USD | Delayed | |
BAVA | Frankfurt | EUR | Delayed | |
BAVA | Vienna | EUR | Real-time |
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2. The company has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Canada, France, Germany, Spain, Australia, Switzerland, Sweden, Chile, Taiwan, the United Kingdom, Hong Kong, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Anders Gersel Pedersen | 71 | 2010 | Deputy Chairman |
Peter H. Kürstein-Jensen | 67 | 2012 | Independent Director |
Karen Merete Jensen | 64 | 2021 | Employee-Elected Member of the Board |
Linette Munksgaard Andersen | 49 | 2021 | Employee-Elected Member of the Board |
Thomas Alex Bennekov | 55 | 2021 | Employee-Elected Member of the Board |
Franciscus A. G. M. Verwiel | 61 | 2015 | Independent Director |
Anja Gjol | 43 | 2021 | Employee-Elected Member of the Board |
Anne Louise Eberhard | 60 | 2019 | Independent Director |
Johan Van Hoof | 67 | 2023 | Independent Director |
Heidi Hunter | 66 | 2023 | Independent Director |
Luc Debruyne | 61 | 2022 | Independent Chairman |
Montse Montaner Picart | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review